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Abstract
Leishmania major is an intracellular parasite which often successfully multiplies and disseminates in a 
body of the host thanks to strategies that help it to escape the components of immune system of the 
host organism. Thus, the parasites evoke an impairment of regulatory pathways that in physiological 
conditions lead to an expression of genes involved in a response to L. major and its efficient 
elimination. Gene targeted deletion, also called gene knock-out, can result in phenotypic alteration and 
associated enhanced susceptibility or resistance of the host. Although such detected genes do not have 
to signify their variability in population and hence they may not be responsible for the worsened
outcome of leishmaniasis of some people necessarily, studies in which they are analysed and general 
knowledge being also a subject of this thesis help us together with techniques of forward genetics to 
reveal the biochemical pathways during the infection and their elements that influence the outcome of 
the disease and might be useful for researches of new medicine drugs or gene therapy. 
Key words: Leishmania major, susceptibility, resistence, targeted mutation, knock-out, immune 
response, Th cell, cytokines
Abstrakt
Leishmania major je intracelulární parazit, kterému se v mnoha případech daří úspěšně množit a šířit 
se v těle hostitele. Děje se tak díky strategiím, pomocí nichž Leishmanie unikají složkám imunitního
systému daného organismu a způsobují narušení regulačních drah, jež za fyziologických podmínek
vedou k expresi genů zapojených v odpovědi na tohoto parazita a jeho úspěšné eliminaci. Cílená 
genová delece, takzvaný genetický knock-out, se může projevit změnou fenotypu a s ním spojenou 
změnou vnímavosti daného hostitelského organismu. Přestože takto detekované geny nemusí být 
v populaci polymorfní a nemusí tak být nutně zodpovědné za zhoršený rozvoj leishmaniózy u 
některých lidí, jejich studie a přehled, jehož zpracování je náplní této práce, mohou společně 
s metodami přímé genetiky pomoci určit biochemické dráhy a jejich prvky ovlivňující celkový projev 
onemocnění a mohou tak usnadnit výzkumy pro tvorbu léčiv či genovou terapii.
Klíčová slova: Leishmania major, vnímavost, rezistence, cílená mutace, knock-out, imunitní 
odpověď, Th buňka, cytokiny
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1 Introduction
Leishmaniasis is an infectious disease originated from several Leishmania species, for instance 
L. major, L. donovani and L. braziliensis, whose uncontrolled replication leads to cutaneous, 
mucocutaneous or visceral syndromes causing e. g. formation of skin and organ lesions, destruction of 
mucous membrane and cartilage in nasal cavity and mouth or worse hypertrophy of spleen and liver. It 
is spread in tropical or dry climate areas mainly in India, Bangladesh, Sudan, South Sudan, Ethiopia 
and Brazil in case of visceral leishmaniasis while cutaneous leishmaniasis appears in Americas, 
Mediterranean areas and Middle East to Central Asia (Alvar et al., 2012).
Leishmania parasites are intracellular pathogens invading macrophages and other phagocytes 
to multiply, extend over the body and finish their life cycle. Even though Leishmania parasites have 
some escaping mechanisms, in majority of cases, the immune system promotes sufficient signalling 
for Th1 response characterized by elevated levels of pro-inflammatory cytokines (IFN-γ, IL-12) and 
decreased cytokines produced by Th2 cells and other immune compounds. Beside others, the balance 
between Th1/Th2 cell development and effective parasite elimination is supposed to be influenced by 
genetic predispositions. 
There are two possible genetic approaches nowadays that can be efficiently used together to 
clarify the presence of products of genes involved in immune response to various pathogens and their 
function and might promise an effective design of treatment. Apart from gene knock-outs which may 
confirm possible significant role of a particular gene in regulation of the outcome of disease, methods
of forward genetics that can not only determine a range of genes responsible for the susceptibility but 
also reveal new ones that participate in concrete biochemical pathways are recently applied. It is also a 
subject of study in the Laboratory of Molecular and Cellular Immunology, ASCR, headed by doc. 
Marie Lipoldová, CSc. who determine QTLs, regions of chromosomes that control specific 
manifestations of the disease, by genotyping specifically bred strains e. g. recombinant congenic 
strains and by comparing their distinct phenotypes (Havelková et al., 2006; Kobets et al., 2012;
Sohrabi et al., 2013; Šíma et al., 2011and others). Still, it is necessary to consider all the aspects of 
vector-parasite-host interactions and their individual features as the laboratory designed experiments 
cannot fully mimic the natural diversity. Moreover, a problem is that people all over the world are 
exposed to different environmental and living conditions which also have an impact on their 
robustness and overall health and not to forget the outcome of the disease resulting from the response 
of immune system of the host to Leishmania parasites is influenced by many genes of minor effects
thus it is demanding to recognize an effect of a single gene only. 
This thesis is aimed to summarize studies of gene targeted null mutations that influence the 
response to L. major in order to understand defensive pathways of immune system which are 
important not only in response to Leishmania parasites but also other intracellular pathogens.
2
2 Leishmaniasis
Leishmaniasis is an infectious disease caused by intracellular parasites of Leishmania genus. It 
is transmitted by bites of sand flies that have become infected when ingesting a blood meal from 
another infected mammal host. The vectors can be located in a damp habitat as well as in subtropical 
and tropical areas all over the world. Specifically, the illness is spread by Lutzomya in the Americas 
and by Phlebotomus in the Old world (Africa, India, south Europe and Middle East) (Herwaldt, 1999).
According to the data collected during 5 or less year periods in years from 2002 to 2010
leishmaniasis threatens over 350 million people living worldwide and there are 98 countries on 5 
continents where it appears constantly (Fig. 1). Moreover, a number of 0.9 to 1.6 million new cases 
and up to 40 thousand deaths may occur annually but it is important to contemplate that it is an 
estimation only as there is a lack of required information especially in countries where most people are 
infected (Alvar et al., 2012). Apart from genetic predispositions, leishmaniasis is related to worsened 
life conditions, malnutrition and lack of professional medical care and depleted immune system which
is possibly caused by mentioned issues or also some associated diseases such as HIV (Alvar et al., 
1997).
2.1 Disease agents
Concerning significant variability in host’s immune response, diversity of vectors and 
Leishmania parasites manifestations of the disease vary from most frequent cutaneous forms, for 
instance self-healing skin ulcers, to damage of nasal and oral mucosa and cartilage. If the most severe 
form, visceral leishmaniasis, occurs the parasites migrate through blood and lymph vessels and destroy 
hematopoietic and filtering organs or nodes. This leads to weakness, fever, weight loss and overall 
immune system crash possibly including anaemia (Herwaldt, 1999). When visceral leishmaniasis
Figure 1: Status of endemicity of cutaneous leishmaniasis, 2013
The figure is taken from http://apps.who.int/neglected_diseases/ntddata/leishmaniasis/leishmaniasis.html 
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Figure 2:  Life cycle of Leishmania
The figure is taken from http://www.cdc.gov/parasites/leishmaniasis/biology.html
disappears it might relapse as so-called post-kala-azar dermal leishmaniasis, chronic form incurred by
Leishmania donovani (Herwaldt, 1999). Thus, we can roughly separate the manifestations into the 
following groups: cutaneous predominantly due to L. major, L. tropica and L. aetiopica in the Old 
world and L. braziliensis, L. mexicana and L. amazoniensis etc. in Americas. Next, mucocutaneous
leishmaniasis located mostly just in South America provoked by L. braziliensis, L. amazoniensis, L. 
mexicana and visceral form generated mainly by L. donovani in the Old world but also by L. infantum, 
or L. tropica (Murray et al., 2005).
2.2 Life cycle of Leishmania major
Leishmania parasites can grow into two morphologically distinct life stages (Fig. 2). First, the 
non-motile amastigotes are ingested by the sand fly from infected blood of a host. Afterwards, 
amastigotes differentiate into flagellated procyclic promastigotes in the sand fly’s midgut. As 
promastigotes divide they simply transform themselves into the metacyclic phase and migrate to a 
pharyngeal valve whence they are injected to another host. Metacyclic promastigotes can actively 
invade macrophages and granulocytes. Later, they convert into amastigotes that multiply inside the 
cells and leave after the burst of the cells into blood vessels. Hence, the amastigotes can both attack 
other cells and escape to another carrier with the blood meal and mature into the infectious 
promastigotes eventually (Murray et al., 2005; Sacks et al., 2002).
2.3 Escape strategies
Leishmania parasites are intracellular protozoa, Kinetoplastida, Trypanosomatida. Kinetoplast, 
a special mitochondria structure of these organisms, contains extra nuclear genetic information for 
mitochondria proteins as so-called maxi-circles and genes for complex system of proteins as mini-
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circles that modify just exactly the DNA of maxi-circles. In other words, in order to obtain functional 
mRNA transcribed from maxi-circles, it is necessary to correct the primary transcript by RNA editing 
via proteins coded in the mini-circles (Lukeš et al., 2002).
Aside from the kinetoplast Leishmania parasites can be characterised by other extra molecules 
principally used against host’s immune system as escape mechanisms. In the view of fact that 
Leishmania parasites create two life stages, extracellular promastigotes in the sand fly’s gut and 
intracellular amastigotes inside phagocyte cells of mammals, it is crucial for them to remain in such a 
diverse environment successfully. Thus, they evolved sophisticated and complex system of surface 
molecules, inhibitors and stimulators against the defence of both the vectors and the hosts in order to 
not only survive but also reproduce and spread effectively.
Surface molecules
The parasite penetrates into the skin from vector’s midgut when being in a stage of metacyclic 
promastigote. It is not able to actively fight against compounds of immune protection but it can escape 
efficiently thanks to a thick layer of glycocalyx consisting of numerous glycoproteins, especially 
lysophosphoglycans (LPGs), glycoinositolphospholipids (GIPLs), glycoproteins 63 or for instance
other proteases, whose roles in the process of evading the immune system are still a subject of research 
(Silvestre et al., 2009).
Expression of LPG differs depending on the particular life stage and its background. 
Therefore, metacyclic promastigotes capitalize on the thick coat probably due to the protection against 
transmitter’s hydrolases and produce longer and more branched LPGs in comparison to procyclic 
promastigotes. This is optimal for them to persist, chiefly, the lysis initiated by complement.  
Amastigotes have the expression of LPG even down-regulated and it is thus believed that its role as a 
protection against immune system is rather insignificant during this life stage (Pimenta et al., 1991 as 
cited in Olivier et al., 2005).
Induced phagocytosis
Apart from LPG, there can be found a protease complex gp63 disrupting an extracellular 
matrix and cleaving an opsonin C3b on the surface of Leishmania parasites hence causing an inability 
of the immune system to assemble complement convertase followed by cell lysis. Therefore, by this 
transformation the phagocytosis is stimulated via secure receptors, meaning, without an activation of 
macrophages. This safe path occurs also when LPGs interact with C-reactive protein and its receptor 
(Olivier et al., 2005).
As the opsonised particle binds to the receptor and is phagocytised, a vesicle, phagosome, 
sprouts. Following a fusion of phagosome and lysosome, the pH decreases markedly which leads to 
digestion of the particle. Subsequently, cleaved molecules are degraded by oxygen radicals after an 
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activation of respiratory burst via protein kinase C or by cytokine-induced nitrite oxide production
(Olivier et al., 2005). How Leishmania parasites manage to defend themselves against these 
mechanisms is yet not completely understood. It is possible that an important role is played by surface 
molecules as the transmembrane residue of LPG connects to another residue of phosphatidyl inositol 
bisphosphate and thus inhibits activity of PKC (and so NADPH oxidase) (Olivier et al., 1992 as cited 
in Olivier et al., 2005). They might also resist thanks to the induction of cytokines that cause the iNO 
synthase suppression and inconvenient stimulation of Th2 immune pathway (Olivier et al., 2005) or 
thanks to peroxidoxines and superoxide dismutase of Leishmania that negatively affect reactive oxide 
intermediates (Ghosh et al., 2003). There is also a chance that cytosolic perforine, so-called leishporin, 
creates pores in the membrane of phagocytes resulting in potential outflow of amastigotes into the 
cytosol (Noronha et al., 2000).
2.4 Efficient immune response to the infection
The immune response to exogenous structures is based on an interaction between elements of 
innate immunity, NK cells (recognizing MHC class I), phagocytes and complement, and of adaptive 
immunity using specific molecules that react to every individual component by activation of T and B 
lymphocytes and creation of antibodies (Fig. 3).
The human immune system literally competes against parasite’s interests. As soon as the 
parasite overcomes mechanical barriers successfully and enters the body of the host, it provokes an 
inflammatory response and thus the tissue damage. Primarily, ever-present neutrophil granulocytes 
followed by macrophages, complement and dendritic cells are assembled to the site of inflammation. 
Figure 3: Th response to L. major (effect of HIV virus also visible)
The figure is taken from (Ezra, et al., 2010)
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Pathogen is therefore effectively defeated by hydrolytic enzymes, respiratory burst or complement-
activated lysis plus all these processes are intensified by secretion of supporting cytokines (Mutiso et 
al., 2013).
Macrophages or dendritic cells can also act as antigen presenting cells (APCs). Such APCs 
present an antigen to T lymphocytes via MHC glycoproteins especially when the nonspecific immune 
system fails. Hence, both of the parts of immunity associate and work together.
Naïve precursors of T lymphocytes, pro-thymocytes, develop in thymus into CD4+CD8+
double-positive T cells with T-cell receptors (TCRs) and CD4/CD8 co-receptors on their surface. 
After an adhesion of MHC-antigen, the co-receptors are filtered and mature CD4+ or CD8+ T helper 
(Th) lymphocytes form. Further differentiation of Th lymphocytes into Th1 or Th2 cells is triggered 
by cytokine signalling and affinity among the antigen and TCR (Miosge et al., 2005). In fact, the 
balance between Th1 and Th2 response can significantly affect the outcome of the disease. When 
Leishmania major infection expands it was demonstrated that a pathway of IL-4-producing Th2 cells
first evolves (Reiner et al., 1994). Nevertheless, it is necessary to shift this pathway in Th1 direction 
initiated by MHC class II and antigen conjunction. This contact helps the TCR receptors to recognize 
the co-receptor-MHC II-antigen complex on the surface of APCs leading to IL-12 release. These 
processes stimulate Th1 cells to produce IFN-γ and other related cytokines resulting in activation of 
STAT and T-bet transcriptional factors as well as macrophages and in an amplification of these signals 
heading to self-healing (Sacks et al., 2002). Consequently, it can be assumed that any disruption of 
production of substances mentioned above contributes to higher susceptibility against leishmaniasis. 
2.5 Susceptibility against Leishmania parasites
At first the distinct outcome of leishmaniasis was supposed to be a consequence of different 
ability to generate an adequate inflammatory Th1 response, however, there are studies noticing an 
explanation of susceptibility only by Th1/Th2 polarization of immune response insufficient. Anderson 
et al. examined the outcome of the disease caused by L. major Sd strain isolated from a patient with 
non-healing lesions. Surprisingly C57BL/6 mice considered to be resistant also showed non-healing 
lesions, ulcers and high parasite burdens. Moreover, it was discovered that these mice infected with 
low dose of 1000 promastigotes had evolved Th1 response as higher level of IFN-γ and corresponding 
lower levels of IL-4 and IL-13 were detected and the induction of iNO synthase and mobilization of 
both CD8+ and CD4+ T cells was not altered. As there was no significant difference between Sd and 
V1 strain of L. major identified and a following experiment with mice deficient in IL-10 gene still 
resulted in inability to fully eliminate the infection, higher susceptibility might have been a result of 
activity of other cytokines (Anderson et al., 2005). Likewise, a study by Noben-Trauth et al. of 
BALB/c mice deficient in IL-4 which is believed to be crucial for Th2 response development 
unexpectedly revealed no significant improvement in a control of the infection and mice infected with 
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2 × 106 L. major LV39 promastigotes failed to resolve the infection (Noben-Trauth et al., 1996). 
Similar conclusions are indicated in studies of gene KOs registering except for Th1/Th2 dichotomy 
other components of signalling pathways participating in the disease manifestation.
In any case, CD4+ T lymphocytes which differentiate into IL-4 producing Th2 cells contribute 
markedly to worsened outcome of the disease as the Th2 development and simultaneous restriction of 
Th1 cells result in inhibition of APC’s function and so the production of IL-12. Moreover, IL-4 and 
other related cytokines, e. g. IL-6, IL-10, IL-13 and TGF-β (Sacks et al., 2002), stimulate B cells to 
produce antibodies that are aimed to extracellular pathogens rather than intracellular ones and thus 
they are useless in the defence. Exactly, high levels of immunoglobulins, IgG, IgM, IgE and IgD
(Gosh, et al., 1995 as cited in Mutiso et al., 2013), are detected mainly in mice suffering visceral 
leishmaniasis when parasites successfully spread into inner organs. This contributes to aggravated 
capability to resist and interfere against the infection (Mutiso et al., 2013).
A cellular environment surrounding the site of inflammation, meaning which cells are more 
likely to be instigated to reproduction and differentiation is also involved in increased sensitivity. It
includes neutrophils, for example, and other granulocytes that persist in profusion for a long time in 
the inflammatory site of more susceptible BALB/c when compared to resistant C57BL/6 strain where 
few neutrophils appear in the site of inflammation temporarily (Beil et al., 1992). In addition, if 
neutrophils were removed the Th2 direction and manifestation of the disease in BALB/c mice were 
weakened (Tacchini-Cottier et al., 2000).
Another important role is played by receptors, IL-12R especially, their ligands and cytokines 
and other effector molecules whose various affinity or even inability of binding affects mechanisms 
linked in the response to infection naturally (Sacks et al., 2002).
Dysfunction of T regulatory (Treg) cells, the T lymphocytes that provide immune supervision 
and tolerance to endogenous antigens, is also associated with the course of leishmaniasis. Even though 
these cells generally influence autoimmune diseases, their competence to produce IL-10 is important 
not only during leishmaniasis but also other infections. That is why Treg cells might support parasites’ 
long term endurance in the body (Belkaid et al., 2002).
It is obvious that both the resistance and susceptibility are not dependent on selection of 
inflammatory or humoral response only. It is a sophisticated complex, a network, of cellular and non-
cellular components, their mutual relations and stimulations of transcription factors and other 
molecules. All these substances are coded in genes that can be monogenous as well as polygenous and 
can exist in linkage or other relations. Therefore it is apparent that polymorphisms existing in the 
population in these genes may have an impact on the course of leishmaniasis. It is yet a subject of 
many researches to determine which genes are responsible for the outcome of the disease but as a 
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mouse-deficient model has been presented and used together with gene mapping a great improvement 
has been marked.
3 Methods
3.1 Recent genetic approaches
Nowadays, there are two methods used for defining genetic basis of diseases, forward and 
reverse genetics. Forward genetics seek candidate genes on the ground of unusual phenotype by 
genotyping inbred strains that could be additionally mutated to raise their mutagenesis rate and 
variability and by mapping the QTLs. The mapped range of genes that is responsible for specific 
phenotypic characteristic may be narrowed to one particular gene in this way. However, it is possible 
and efficient to apply reverse genetics too when we hypothesize the exact gene to be involved. Thus 
we modify it and analyse the effects of the gene alteration on the resultant phenotype which can reveal 
us whether the gene of our interest is indeed in the pathways that regulate the outcome of the disease 
(Ermann et al., 2012).
Forward genetics
A change of the phenotype might be induced in forward genetics by random mutagenesis and 
hence we can discover plenty of new genes participating in a response to specific pathogen quite 
quickly in comparison to naturally occurring spontaneous mutations. The most frequent methods of 
mutagenesis are application of X-rays or some chemical mutagens such as N-ethyl-N-nitrosourea 
(ENU) or the ability of transposons to transfer and insert a DNA sequence into the genome and cause a 
mutation by cut and paste or copy and paste mechanisms is also widely used (Weyden et al., 2011).
To map genes included in a response to diseases such as leishmaniasis, special mouse strains 
differing in size and frequency of parental DNA segments in the genome are cross-bred to make the 
detection of the genes and specification of their position on the chromosomes easier. For example, 
recombinant inbred strains (RIS) are therefore generated by crossing two homozygous strains whose 
genetically identical heterozygous descendants of F1 generation are inbred to make new homozygous 
strains carrying 50 % of the genes of one parent and 50 % of the other one. Unlike the RIS, 
recombinant congenic strains are formed by backcrossing the progeny of two inbred strains usually for 
20 generations or more with exactly one of the homozygous parent resulting in a creation of new 
strains containing 12.5 % of the genome of the donor and 87.5 % of the genome of the acceptor. To 
generate advanced intercross lines (AILs) the strains for the crossing are selected in a way to retain 
maximum possible number of recombination so the parental DNA segments in the genome are shorten 
which helps to map the genes more precisely. Another possible option is for instance a use of 
heterozygous stocks, mouse strains that are created by crossing several inbred parental strains 
(Demant, 2003).
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Reverse genetics and gene targeting
The targeted modification of nuclear genetic information being a tool of reverse genetics was 
first successful when injecting plasmid DNA of HSV-tk (Herpes simplex virus - thimidine kinase) 
using glass needle into the cell nucleus where it incorporated into the genome as a result of 
homologous recombination. Contrary to previous experiments the incorporation of the vector with a 
specific sequence into the gene of interest and transition of this modified genetic information to the 
next cell generation has been successful (Capecchi, 2001).
Gene knock-out
One of the most common methods of reverse genetics used for exploring the metabolic 
pathways is gene knock-out where homologous recombination, use of replacement or insertion 
vectors, integration of adjusted DNA into the embryo-derived stem cell and additional selection via 
specific markers in the vector and their inducers are the key steps. Better analysis is ensured by the 
opportunity to choose the modified cells through the positive-negative selection (Fig. 4). Apart from 
homologous sections and specific sequence inserted, this filtration is allowed thanks to a sequence for 
antibiotic resistance (e. g. neomycin) and a virus gene, HSV-tk which is attached to one end of 
linearized vector. Therefore, we can pick all of the cells with incorporated vector (i. e. positive 
selection via neomycin) and at the same time we can filter out the cells where the vector integrated 
non-homologously (negative selection via antiviral HSV-tk). These designed cells can be injected into 
embryonic stage of blastocyst and transferred to a foster mother. Chimeras generated eventually are 
backcrossed with both the homozygotes and heterozygotes in order to achieve wild type and 
heterozygous phenotype as well as homozygous mice that have both of the alleles modified (Capecchi, 
2001).
Figure 4: Positive-negative selection. Homologous recombination with the target gene 
introduces only neor; whereas random integration with random gene inserts both neor and tk.
The figure is taken from http://proj.ncku.edu.tw/research/commentary/e/20071116/2.html
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Today several options of targeted mutations exist. Apart from the gene knock-out other 
methods such as subtle mutations by hit and run mechanism, when the vector is excised with the 
targeted gene after its integration or so-called knock-in of the targeted gene, when we can basically 
exchange any gene for the intended one are in use (Weyden et al., 2002).
Site-specific DNA recombination
Site-specific DNA recombination with a vector that is integrated into the genome of the host 
and contains extra sequences for regulators of the transcription is also amply implemented, especially 
a system of Cre site-spesific recombinases (Weyden et al., 2011) that was also applied in two studies 
of gene deficient mice infected by L. major (Auderset et al., 2012, Kinjyo et al., 2006) mentioned in 
this thesis.
Compared to the knockout the gene of our interest is not completely inactivated but it is 
usually replaced by its analogue. Specific Cre recombinase or some other recognizes loxP sequences 
inserted by homologous recombination into the recipient which hence becomes floxed. The gene for 
Cre recombinase, that generally contains a promoter activated in specific tissue only or in a presence 
of specific stimulating substance, is brought into the second recipient. When both mice, one of them is 
floxed and the other has Cre gene incorporated, are crossed the targeted gene is cut out only in the site 
of effective transcription of Cre recombinase (Weyden et al., 2002).
Although this method is quite exacting it allows a prevention of embryos from extinction 
caused by potentially lethal null mutation when realizing the classical knock-out. It also decreases the 
probability of deleted gene’s compensation mediated by another gene. In other words, it is possible to 
generate numerous mutations and examine their impacts that may differ in various tissues. But there is 
still a potential problem with an occurrence of natural recombination through cryptic loxP-like 
sequences (Weyden et al., 2002).
RNA interference
A silencing of gene transcription via RNA interference is also worth mentioning. The down-
regulatory pathway is activated by DICER enzyme after recognition of RNA (e. g. shRNA) introduced 
into the genome of the host that pairs with the targeted DNA sequence. DICER cleaves such dsRNA to 
siRNA which associates with RISC and then together they degrade other mRNAs complementary to 
such siRNA (Gao et al., 2007). 
Programmable nucleases
The latest procedures that may once replace time- and finance- consuming knock-outs and 
their variations are genome editing via programmable nucleases. Zinc-finger (ZF) and newer 
transcription activator like (TALE) and RNA-guided engineered (RGE) nucleases differing in 
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targetable location produce site-specific double strand breaks and then induce the correction by non-
homologous end joining mechanism leading to targeted alteration of the genome, point mutations or 
even chromosomal aberrations such as inversions or translocations. In addition following the creation 
of double strand breaks, more accurate homologous recombination is possible in case of realization of 
DNA insertion via vector into the genome of the host (Kim and Kim, 2014).
It is remarkably helpful to understand how both the pathogen and host defend their interests 
and how exactly their individual proteins and other molecules interact while searching for the vaccine. 
Techniques of forward genetics together with gene targeting yet achieves probably the most effective 
results when identifying candidate genes involving symptoms of numerous diseases including 
leishmaniasis and role of human immune system.
3.2 In vivo infection with Leishmania major
Methods of analysis of gene deficient mice infected with L. major vary among different 
research groups. They may choose distinct mouse strains as well as diverse parasite’s species which 
may have an impact on the results they obtain as resistance to L. major of some strains might be
dependent on early IL-12 production and of others rather not (Demant, 1996).
Mouse strains
Despite the mouse model offers great advantages to study molecular and genetic processes 
thanks to its relative similarities with human genome, short life cycle and easy manipulation (Weyden
et al., 2002), the research is often aimed to the mouse models only thereby mouse-human differences 
and distinct biochemical pathways of individuals are substantially omitted. It is thus very convenient 
to examine other mouse strains with diverse genetic background apart from the most widely used 
susceptible BALB/c and resistant C57BL/6 because it would in fact take account of naturally 
occurring variability in human population (Ermann et al., 2012). Examples might be susceptible MAI 
(Babay et al., 2004) or P/J, SWR/J a CcS-16 (Lipoldová et al., 2006) strains and resistant PWK (Babay
et al., 2004) or B10.D2, CBA, C3H, STS, 129/Sv, CcS-5 (Lipoldová et al., 2006). Following mouse 
strains were used in studies described here of gene KOs examined during L. major infection.
C57BL
C57BL and its substrain C57BL/6 also called black 6 (B6) for its black-coloured hair is
probably the most frequent inbred strain used in numerous experiments. C57BL was firstly inbred by 
the founder of Jacksons Laboratory C. C. Little (The Jackson Laboratory, 2014).  It is widely used 
thanks to its availability, strain stability and easy breeding. The strain is also known for its resistance 
against tumour growth, convenient environment to express modified genes and increased 
inflammatory response. When infected with L. major it shows significant resistance and ability to heal. 
In comparison to other strains such as BALB/c or DBA/2J it lives longer. C57BL helps not only in 
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immunology and parasitic diseases but also in diabetes, obesity, neurobiology and cardiovascular 
fields of study. Individual strains may differ in order to laboratory to be generated in (e. g. Jacksons 
and Harlan laboratories) (Festing, 1998).
129
Most substrains of 129 are light or white-coloured and thus they are often crossed with dark 
C57BL/6 mice when doing gene targeting since it is easy to find out whether the incorporation of 
mutation was successful by observing the hair colour of such designed transgenic mice. It is applied in 
immunology and cancer research as several lines of embryo-derived stem cells are easily accessible, 
however, 129 mice have poor breeding performance and the substrains genetically vary (Festing, 
1998).
C3H
C3H mice used in various researches of cancer and infectious diseases included are also 
resistant to L. major and have a high rate of spontaneous mutations that also occurred in C3H/HeJ 
substrain at the lipopolysaccharide locus making it more resistant to endotoxin while other strains are 
endotoxin sensitive. Majority of subtrains have a good breeding performance and exhibit very low 
aggression only (Festing, 1998).  
BALB/c
BALB/c are albino mice highly sensitive to Leishmania parasites (and other pathogens e. g. 
some species of Salmonella, Helicobacter or Trypanosoma) that are unable to control the infection 
and hence the infection might lead to fatal visceral form. Despite some substrains (for instance 
BALB/cJ) are very aggressive, they are used for examining abnormalities of immune response 
considering their susceptibility against several pathogens and for creating recombinant congenic 
strains when mapping genetic variability (Festing, 1998).
Parasites
It has been proven in a study of Dr. Nancy Noben-Trauth who had discovered apart from 
probable minor role of IL-4 in response to L. major (see above) that IL-4Rα-/- deficient BALB/c mice 
infected with L. major LV39 strain remain susceptible whereas mice infected with IR173 strain were 
highly resistant and in some cases they could control the infection even better than C57BL/6 mice 
(Nobe-Trauth, 2000). The outcome of the disease hence depends on several aspects including mouse 
and parasite species thus it is necessary to take them all into consideration when preparing an 
experiment. 
The number of inoculated parasites has been showed to be important as well. Using real-time 
PCR, the Laboratory of Parasitic Diseases and Immunology led by Nicola Kimblin attempted to 
determine the number of parasites that can be transmitted into the host by single vector. If an intake of 
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blood meal and transmission that could be detected via fluorescent markers in parasites occurred, the 
number of transferred promastigotes ranged between ten to hundreds and thousands. Approximately 
75 % of infected mice contained less than 600 parasites possibly as a result of interruption during the 
intake. The remaining 25% of mice showed more than 1000 promastigotes which might be the cause 
of blood meal’s passive back-flow in the vector rather than a formation of a plug made from gel 
secreted by parasites (Kimblin et al., 2008). 
When analysing the impact of parasite’s dose injected into mice in laboratory conditions, high 
doses evoked lesion creation immediately while low doses surprisingly displayed more parasites 
persisting in the body of the host and thus created new reservoir. The research is rather aimed to more 
frequent cutaneous leishmanisis and as it is performed in artificial environment the higher doses used 
in many experiments seem to be adequate (Kimblin et al., 2008).
Promastigotes were inoculated intradermally or subcutaneously into different parts of mouse 
body, most commonly into the ears and hind footpads in all studies discussed in this thesis and the 
dose of parasites injected into mice varied from 102 to 107 but most often it was 106 Leishmania
parasites.
4 Targeted mutations enhancing the susceptibility against L. major
An overview of the gene KOs described here with details of mouse and parasite strains and the 
outcomes of leishmaniasis can be found in the attachment as well as a map of signalling pathways 
influenced by these genes and illustration of genes’ approximate positions on chromosomes.
4.1 Genes involved in Jak/Stat signalling pathway
APCs produce specific cytokines influencing the differentiation of CD4+ T helper cells into 
Th1 or Th2 lymphocytes. Such lymphocytes direct the immune response against Leishmania parasites 
by secreting distinct signal molecules. IFN-γ together with IL-12 provide the Th1 response direction 
and its maintenance as they activate the macrophages and inhibit Th2 cells simultaneously leading to 
an efficient elimination of intracellular parasites of Leishmania or other genus as well (Wang et al., 
1994). One of the first works that used gene targeted null mutation to clarify Th1/Th2 dichotomy of 
immune response to leishmaniasis concerns immediately the role of IFN-γ in defence mechanisms. 
Ifng
The research group of Wang et al. from University of California analysed progression of the 
disease in mice on C57BL/6 resistant background with Ifng gene knocked out and infected with 106
promastigotes inoculated into the hind footpads (Wang et al., 1994). Infected mice developed large 
lesions gradually, hypertrophy of lymph nodes and spleen and even sudden death of some mice 
occurred 5 to 7 weeks post infection most probably due to fully expanded Th2 response since higher 
levels of IL-4, IL-5, IL-13 cytokines and IgG1 and IgE antibodies have been detected (Wang et al., 
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1994). In physiological conditions IFN-γ triggers a phosphorylation cascade by activating Janus 
kinases JAK1 and JAK2 leading to a translocation of STATs into nucleus where T-bet transcription 
factor that inhibits IL-4 and IL-5 production and at the same time strengthens its own transcription is 
expressed (Thomson Reuters, 2013). On the basis of this signalling pathway the results have showed 
markedly enhanced susceptibility to L. major as expected and crucial role of IFN-γ in Th 
differentiation as well as in later control of infection and disease resolution.
Socs1
Suppressors of cytokine signalling (SOCSs) are expressed when stimulated with IFN-γ whose 
production they supress afterwards and thereby negatively regulate JAK/STAT pathway (Bullen et al., 
2003). Thus, when SOCS1 is absent an overproduction of IFN-γ contributing to overall resistance of 
the host might be presumed. Increased level of IFN-γ and concurrently decreased levels of IL-4 and 
IL-10 in mice on resistant background deficient in one copy of Socs1 infected with 104 promastigotes 
inoculated intradermally into the pinna of the ear were detected indeed (Bullen et al., 2003). In spite of 
the presence of cytokines indicating Th1 immune response these mice surprisingly displayed 
persisting lesions and delayed healing phenotype in comparison to wild type (WT) mice. Furthermore, 
if mice with both copies of Socs1 deleted were infected they died very soon, in most of the cases in 2 
to 4 weeks post infection (Bullen et al., 2003). Socs1 KO promotes an activation of IL-12 induced 
STAT4 and IL-4 induced STAT6 that stimulate both Th1 (STAT4) and Th2 (STAT6) cells (Fujimoto, 
et al., 2002) plus in mice lacking SOCS1 there was no significant alteration of Th2 cytokine levels 
observed (Bullen et al., 2003). Together these data suggest a role of SOCS1 in regulation and 
maintenance of the balance of cytokine signalling mediated by both Th1 and Th2 cells probably 
during parasites’ persistence rather than at a time of T cell differentiation (Bullen et al., 2003).
Socs3
To analyse immune response to Leishmania parasites in Socs3-/- deficient mice on resistant 
background infected with 107 promastigotes inoculated subcutaneously in the right footpad Cre-LoxP 
system of targeted mutations was used (Kinjyo et al., 2006). In comparison to WT mice, higher 
parasite burdens and increased levels of IL-10 and TGF-β leading to delayed healing were noticed in 
mice missing SOCS3, however, footpad swelling, IFN-γ and IL-4 production were comparable 
(Kinjyo et al., 2006). This implies dominant generation of Th3 cells that secrete large amounts of 
exactly TGF-β and weaken both Th1 and Th2 lymphocytes. Therefore, suppressive activity of SOCS3 
that inhibits both IL-12 mediated STAT4 and IL-10 mediated STAT3 signalling via suppression of 
JAK and primarily Th3 differentiation is necessary to control the infection (Kinjyo et al., 2006).
Stat1
STAT1, a signal transducer and activator of transcription 1, is activated mainly by IFN-γ but 
also by other JAK1 mediated cytokines (for instance IL-27 or IL-6) that induce JAK/STAT 
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cooperation. This interference results in expression of IL-12, TNF and iNOS too which all take 
significant part in an elimination of Leishmania parasites (Späth et al., 2009). 
Rosas et al. aimed their research to investigate IFN-γ mediated STAT1 signalling pathway and 
its task in a response to L. major hence Stat1-/- deficient mice on resistant C57BL/6 background were 
infected with 2 × 106 promastigotes injected in the hind footpad. The infection manifested lesions even 
larger than those observed in highly susceptible BALB/c mice (Rosas et al., 2003). Moreover, in a 
similar experiment parasites could survive easily inside a phagolysosome of Stat1 deficient mouse 
macrophages as a phagosomal acidification was disrupted most likely due to a dysfunction of chloride 
channels (Späth et al., 2009). There were greater amounts of IL-10 and less but detectable IFN-γ and 
IL-12 monitored in lymph node cells thereby a loss of control over dissemination of parasites occurred 
following disarrayed production of NO in macrophages (Rosas et al., 2003). As IL-4 production was 
not affected even though in the absence of STAT1 increased levels might have been awaited, these 
results suggest an activity of JAK/STAT independent signalling and its ability to produce some IFN-γ 
that can supress Th2 response firstly but later is not sufficient enough and fails to resolve the infection 
totally. Thus, the outcome of the disease and control over the infection are caused not only by IFN-γ 
dependent STAT1 signalling leading to an activation of T-bet transcription factor but also by other 
mechanisms that are at least partially capable of compensation of this pathway (Rosas et al., 2003). 
Stat4
The previous studies of Kinjoyo and Rosas research groups mentioned above showed that the 
progress of leishmaniasis is not dependent on Th1/Th2 differentiation only. Another laboratory that 
had examined the role of IL-12 activated STAT4 that just as STAT1 induces IFN-γ production also 
came to this conclusion (Stamm et al., 1999). Following an inoculation of 2 × 106 promastigotes in the 
hind footpads of Stat4-/- deficient mice generated on resistant background, larger progressive non-
healing lesions and parasite burdens developed when compared to WT. The presence of IL-12 and 
small amounts of both IFN-γ and IL-4 indicate an existence of STAT4 independent IL-12 pathway 
which stimulates T lymphocytes into Th1 response despite the KO of this signal regulator. Yet, the 
alternative signalling was not sufficient as in the previous case of STAT1 deficiency and thus the lack 
of STAT4 resulted in enhanced susceptibility to L. major (Stamm et al., 1999).
Il27r
IL27R, also called T-cell cytokine receptor (TCCR) or WSX-1, is a receptor of cytokine 
family class I. Yoshida et al. explored the outcome of leishmaniasis in Il27r-/- deficient mice 
backcrossed on resistant background and infected with 5 × 106 promastigotes injected subcutaneously 
in the right hind footpad (Yoshida et al., 2001). The course of infection was greatly worsened in 
comparison to WT, nevertheless, BALB/c still exhibited more severe signs of the disease. Low level 
of IFN-γ had been noted 2 weeks post infection but it raised and corresponded to the production of 
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IFN-γ in WT mice after 5 to 6 weeks (Yoshida et al., 2001). It is likely that IL27R is essential during 
initial stages of infection although it is dispensable later on. The presence of IgG1 and IgE antibodies 
signifies substantial activity of Th2 cells (Yoshida et al., 2001) but it was rather an attenuation of 
STAT1 signalling and associated disruption of Th1 and T-bet stimulation which is regularly supported 
by IL27R during the polarization of immune response (Takeda et al., 2003).
Il6
Resistant Il6-/- deficient mice were infected with 104 promastigotes of L. major or alternatively 
of L. major with CpG DNA inserted because Mendez, Wu et al. had discovered that the infection with 
this genetically modified strain exhibited more moderate outcome of the disease in their preceding 
study and hence they have decided to include it in the analysis of Il6 KO. Surprisingly both of the 
strains of L. major caused a formation of large non-healing lesions and necrosis of the tissue in the site 
of infection (Wu et al., 2009). Contrary to WT, the level of IL-10 was elevated possibly because of 
intensified proliferation of IL-10 secreting Treg cells. KO mice infected with L. major alone showed 
the most aggravated course of the infection from all tested mouse models used in this experiment 
which might be explained by relative success of application of modified parasites that did not affect 
the production of IFN-γ and IL-12 that much (Wu et al., 2009). Considering the positive influence of 
IL-6 on JAK/STAT signalling pathway as well as on NF-κB factor (Thomson Reuters, 2013) we may 
predict its role in a defence to intracellular parasites in initiating STAT dependent pathways exactly 
heading to an activation of T-bet or NF-κB mediated pro-inflammatory cytokines.
Bcl6
BCL6, B-cell lymphoma 6, regulates the differentiation of T lymphocytes by shifting Th1/Th2 
response and also by an alteration of STAT signalling (Dent et al., 1999). The function of Bcl6 in 
immune system during leishmaniasis was inspected by generating its null mutation in resistant mice 
infected with 106 promastigotes subcutaneously in the right hind footpad. Numerous skin ulcers, 
necrosis of tissue and comparable parasite loads as well as typical Th2 cytokines, IL-4, IL-5 and IL-
13, appeared in KO mice just as in BALB/c but the production of IFN-γ was not that affected (Dent et 
al., 1999). These results clearly demonstrate a development of Th2 cells and enhanced susceptibility 
that was in accordance to the influence of BCL6 to GATA-3 which stimulates an expression of 
mentioned cytokines in physiological conditions. The role of IL-4 seemed to be rather minor as the 
outcome of the disease in Bcl6-/-Il4-/- double KO mice displayed nearly the same levels of IL-13 and 
IL-5 as in Bcl6-/- KO but was exacerbated when compared to WT or Il4-/- KO. Dent et al. had 
performed other experiments and proved a dependence of enhanced susceptibility on STAT6 which is 
predominantly induced by IL-13 and whose absence in Bcl6-/- deficient mice converted vulnerable 
ones into resistant (Dent et al., 1999). 
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4.2 Genes involved in NF-κB and MAPK signalling pathways
Nfκb
Various stimuli can initiate a cascade of reactions leading to a deactivation of IκB followed by 
a stimulation of NF-κB which helps to express other factors whether they stimulate cells to proliferate, 
urge them to an angiogenesis or a tissue invasion or pass on a survival signal (Artis et al., 2003). Such 
complexity of this signalling and all the compounds involved suggests a significant position in 
immunity. The task of NF-κB during leishmaniasis was investigated by Artis et al. from University of 
Pennsylvania, Department of Pathobiology on Nfkb1-/- deficient mice backcrossed on resistant 
C57BL/6 background inoculated with 5 × 106 promastigotes injected in the hind footpad. The infection 
culminated in chronic non-healing lesions apparently due to reduced proliferation of antigen specific 
CD4+ T cells producing IFN-γ (Artis et al., 2003). There were no noteworthy changes in production of 
neither IL-12 nor NO detected in comparison to WT but when Nfkb2 KO was realized the production 
of NO was impaired. Altogether, the susceptibility of mice lacking NF-κB2 might be a cause of 
decreased IL-12 secretion while in mice lacking NF-κB1 disrupted signalling to the proliferation via 
molecules such as IL-1, IL-6 or TNF necessary for a correct immune response of CD4+ T cells is 
probably responsible (Artis et al., 2003).
Ccr2
One of such impulses that activate NF-κB is chemokine receptor CCR2. KO of Ccr2 in mice 
backcrossed on the resistant background and infected with 2 × 106 promastigotes inoculated 
intradermally into both ears seems to play an important role in maturation and migration of dendritic 
cells and resultant production of IL-12 and thus Th1 differentiation (Jimenez et al., 2010). Actually, 
the level of IL-12 was markedly reduced as well as the expression of CCL19 chemokine and MHC 
class II which is located on the surface of DCs and that are both responsible for proper behaviour and 
migration of DCs. Therefore, the enhanced susceptibility to leishmaniasis is also related to the 
function of CCR2 which moves NF-κB to translocate into the nucleus and so influences the expression 
of other effector molecules (Jimenez et al., 2010).
Il1ra
IL-1 receptor antagonist (IL-1RA) blocks an access of IL-1 to its receptor and restrains 
negative effects of IL-1 overexpression as its signalling via TRAF6 supresses NF-κB thus the outcome 
of leishmaniasis should be worsened in IL1RA deficient mice theoretically (Voronov et al., 2010). 
Indeed, elevated levels of IL-4, IL-6, IL-10 and IL-17 cytokines and connected aggravation of 
infection were observed in comparison to Il1KO and even BALB/c (Voronov et al., 2010). Similar 
conclusions were deduced when Il1ra KO was performed on BALB/c mice infected with 103
promastigotes inoculated intradermally in ear skin as they also exhibited enhanced susceptibility 
associated with low levels of IFN-γ, IL-12, increased levels of Th2 cytokines and with more 
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neutrophils and DCs accumulated in the site of infection causing partial damage of tissue (Kautz-Neu
et al., 2011).
Notch
Notch1 and Notch2 receptors regulate both GATA-3 and NF-κB factors through recombining 
binding protein suppressor (RBP-J) thereby they influence differentiation and proliferation of T 
lymphocytes and production of specific cytokines. In case of only one of the Notch being knocked out, 
mice were resistant to L. major even though Notch1 is more likely to be the dominant one as its 
expression prevailed over Notch2 in control mice. Double KO in mice on C57BL/6 genetic 
background was examined after an exposure to 3 × 106 promastigotes injected in the footpad (Auderset
et al., 2012). As a consequence of the deficiency of both Notch receptors contributing to low IFN-γ 
and high IL-5 and IL-13 content T cells were not able to produce enough IFN-γ and fully develop Th1 
response. There is also an indication for a direct effect of Notch on IL-4 promoter because there was 
no modulation found in comparison to IL-5 and IL-13 levels although all of these cytokines are under 
the control of GATA-3 (Auderset et al., 2012).
Lgals3
Galectin 3 plays a role in numerous cellular functions including apoptosis, innate immunity, 
cell adhesion and T-cell regulation and it also acts similarly as TLRs. The absence of Lgals3 in 
BALB/c mice infected with L. major provoked in strengthened proliferation of IL-10 secreting Treg 
cells (Fermino et al., 2013). A crucial role of IL-10 alone in a response to L. major was introduced in a 
study of its KO in BALB/c mice leading to enhanced resistance (Kane et al., 2001). Alike in already 
mentioned experiment of Wu et al. with Il6-/- C57BL/6 mice, increased secretion of IL-10 in mice 
lacking galectin 3 resulted in enhanced sensitivity and in this case influencing expression of Notch 
receptors. In addition Treg cells were present at the site of infection in profusion conducing to a 
creation of lesions. The migration of Treg cell to the site of infection might be related to raised activity 
of DCs as Lgals3 attenuates it normally (Fermino et al., 2013).
Cd40l
Glycoprotein CD40 ligand expressed on a surface of CD4+ T lymphocytes takes part not only 
in humoral immunity when stimulating isotype switching of antibodies but also in cellular immunity 
where its importance is based on an elimination of infected cells via interaction with receptors of death 
and an initiation of NF-κB and MAPKs pathways through TRAF factor and subsequent activation of 
macrophages (Thomson Reuters, 2013). Hence, the KO of Cd40l in resistant mice infected with 2 - 5 × 
105 promastigotes in the hind footpad obviously came to defect in IFN-γ, IL-2 and IL-12 production 
and elevated IL-4 levels. The exacerbated course of infection is therefore caused most probably by 
failure of Th1 response generation (Campbell et al., 1996).
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Myd88
Research group of Muraille et al. seeking for potential factors involved in the outcome of 
leishmaniasis engaged to Myeloid differentiation marker, MyD88. Resistant mice deficient in this 
gene and infected with 5 × 106 promastigotes inoculated subcutaneously in the left hind footpad 
evoked typical Th2 response with phenotype similar to BALB/c (Muraille et al., 2003). MyD88 
interferes with TLRs which recognise wide range of pathogens on the ground of common patterns 
such as LPS and lipoproteins. It is possible that the enhanced susceptibility in MyD88 deficient mice 
is connected to an impairment of TLRs signalling as the bond between these patterns and TLRs 
triggers MAPKs and NF-κB pathways through MyD88 heading to the production of cytokines that 
launch a respiratory burst or Fas-mediated apoptosis of infected cells (Muraille et al., 2003). 
Tlr
The hypothesis of TLRs contributing to the outcome of the disease was tested by Fakher et al. 
from Institute of Pasteur in Paris who analysed functions of TLR2, TLR4 and TLR9 by targeted 
mutations in mice backcrossed on resistant C57BL/6 background infected with 3 × 106 promastigotes 
(Fakher et al., 2009). The course of infection with L. major worsened in TLR9 deficient mice only. An 
absence of this gene evinced a suppression of IL-12 and IFN-γ expression and linked inability of 
efficient response to Leishmania parasites (Fakher et al., 2009).
Mif
MIF, migration inhibitory factor, is a cytokine which reduces anti-inflammatory effects and 
helps to produce TNF and NO. Potentially important role of MIF in defence system of the host against 
intracellular parasites was the subject of the work by Satoskar et al. implementing null mutation of Mif
in resistant mice (Satoskar et al., 2001). KO mice infected with 2 × 106 promastigotes inoculated in the 
hind footpad manifested greater parasite burdens and large non-healing lesions in later stages of 
infection. Furthermore, the production of cytokines specific for an invasion of intracellular parasite 
was not modified suggesting that MIF has no impact on the activation and differentiation of T cells. 
Nevertheless, high IL-6 content was observed (Satoskar et al., 2001). IL-6 can induce the expression 
of IFN-γ as explained above (Wu et al., 2009) but it can inhibit the expression too when reacting with 
SOCS3 suppressor. Following the suppression NO production by macrophages may have not been 
realized which could be the reason of ineffective parasite elimination (Satoskar et al., 2001).
Ras
Individual isoforms of Ras factor are activated by binding to TCR receptors but they have no 
significant effects on maturation and differentiation of T cells as an experiment of Ras-/- deficient mice 
on resistant background has showed (Iborra et al., 2011).  A low dose of 300 promastigotes inoculated 
intradermaly into ears of these mice did not alter the production of IL-12 and NO in comparison to 
WT and the level of IL-4 increased up to several weeks post infection. However, IFN-γ was greatly 
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reduced due to the disruption of Ras signalling which is involved in proliferation and apoptosis of 
CD4+ T cells through MAPKs. This experiment as well as many others confirmed the critical role of 
IFN-γ as one of the most important cytokines in the defence of the host (Iborra et al., 2011). 
Jnk1
On the other hand, Jnk1-/- mice generated on resistant background infected with 2 × 106
promastigotes inoculated in the right hind footpad were able to develop Th1 immune response as no 
change of pro-inflammatory cytokines was noted. Yet it was not sufficient enough to repress the 
activity of Th2 cells that secreted significantly higher amounts of IL-5, IL-13 and Th2 dependent IgG1 
antibodies. The inhibition of Th2 cytokines via JNK1 appeared to be necessary in control of 
leishmaniasis in physiological conditions although the phenotype was not as severe as in BALB/c
(Constant et al., 2000).
MhcII
MHC class II is a glycoprotein supporting an interaction between antigen presenting cell and 
T-cell receptor which binds such complex (antigen-MHC-APC) and starts a cascade of reactions 
evoking an adequate immune response (Chakkalath et al., 1995). Surprisingly, mice with MhcII
knocked out backcrossed to C57BL/6 background and infected with 105 promastigotes were able to 
handle the infection at the beginning even better than BALB/c but contrary to WT the level of IFN-γ 
was decreased. This course is most likely on account of CD8+ T cells and their ability to produce small 
amounts of IFN-γ which were sufficient in early stages, nonetheless, MHC II deficient mice succumb 
the infection eventually (Chakkalath et al., 1995).
4.3 Genes involved in apoptotic pathways
IER3, Fas and Fas ligand and TNF are the products of genes that regulate proliferation and cell 
differentiation and one of their main tasks in immune system is to present a signal of death to infected 
cells and regulate MAPKs pathway (Akilov et al., 2009; Conceicao-Silva et al., 1998; Wilhelm et al., 
2001). Infection of resistant mice lacking the single gene each time did not affect Th differentiation 
but led to loss of control over the replication of parasites as NO production was disrupted and 
accumulation of infected macrophages which resulted in a formation of lesions and tissue necrosis at 
the site of infection (Akilov et al., 2009; Conceicao-Silva et al., 1998; Wilhelm et al., 2001). Moreover 
at the beginning of infection of Ier3 deficient mice elevated level of IL-17 was detected which 
corresponds to its function in recruiting neutrophils to the site of inflammation (Akilov et al., 2009).
5 Targeted mutations enhancing the resistance against L. major
Il13
The analysis of effects of Bcl6 KO already mentioned led not only to clarification of its 
function during inflammatory response but also to revelation of STAT6 whose lack enhanced the 
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resistance. STAT6 is induced by IL-4 and IL-13 and it has been also discovered that IL-13 alone is 
able to modulate the activity of Th cells in contrary to IL-4 of which the deficiency in Bcl6 KO mice 
had rather no additive effects on the course of infection (Dent et al., 1999). Thus, Matthews et al. 
decided to investigate whether the KO of Il13 has such impact on BALB/c mice infected with L. 
major. Indeed, when IL-13 was absent Th1 cells were not restricted in production of pro-inflammatory 
cytokines and the mice showed enhanced resistance. Additionally when double Il4-/- Il13-/- KO mice 
were infected they could control leishmaniasis with ease (Matthews et al., 2000).
Il1
An importance of IL-1 regulation has already been proven in the study of IL-1RA (Kautz-Neu
et al., 2011, Voronov et al., 2010). Possible effects of IL-1 which signals an expression of adhesion 
molecules on endothelial cells and leukocytes albeit its role in immune system is much more 
complicated were examined in Il1-/- deficient Babl/c mice infected with 107 promastigotes 
subcutaneously at the base of the tail (Voronov et al., 2010). As expected, moderated manifestations of 
leishmaniasis occurred most possibly thanks to enabled TRAF6-NF-κB signalling leading to an 
expression of T-bet factor and directing the production of Th1 cytokines, IL-12, IFN-γ and IL-18 that 
were present in IL-1 deficient mice (Voronov et al., 2010).
Il17
A function of another cytokine, IL-17, was studied on Il17-/- deficient BALB/c mice. Despite 
Th2 immune response evolved in these mice which was indicated by the levels of IFN-γ, IL-4 and IL-
10 cytokines similar to BALB/c WT, the outcome of the disease was much less severe (Kostka et al., 
2009). This might be a result of IL-17 ability to recruit neutrophils and DCs to the site of inflammation 
where the cells accumulate and hence they can disrupt the tissue later on (Akilov et al., 2009, Kostka
et al., 2009).
Ccl2
Mice generated on resistant background lacking Ccl2 chemokine gene (also called Mcp1) 
displayed strengthen defiance during the infection of L. major in comparison to WT as no MCP-1 
stimulation of the expression of Th2 cytokines, IL-4, IL-5 and IL-10, was therefore achievable (Gu et 
al., 2000). BALB/c mice with Mcp1 KO also moderated the symptoms. They had less footpad 
swelling and were able to stabilize the lesions to some extent so the phenotype they exhibited was 
intermediate between susceptible and resistant strains (Gu et al., 2000). 
Itgam
Apart from principal cytokines it is necessary not to forget the interaction between the parasite 
and surface molecules on phagocytic cells. For instance it is a chemokine receptor ITGAM (CR3)
which binds lysophosphoglycan of Leishmania parasites thereby the promastigotes can penetrate into 
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the cells. In order to this mechanism of invasion when Itgam is knocked out the course of infection 
gets somewhat better but more importantly, part of this receptor, a chain CD11b, transpired to be the 
one which interacts with various patterns of exogenous pathogens in the view of fact that its deficiency 
rapidly enhanced the resistance in BALB/c mice as the parasite could not have entered the cells 
(Carter et al., 2009).
Ahr
Aryl hydrocarbon receptor interferes with STAT1 and NF-κB whose activity is therefore 
attenuated (Kimura, et al., 2009). In spite of its KO in resistant mice during L. major infection that 
modulated the production of cytokines, as low IL-12 and high IL-10 content was observed at first 
probably due to increased level of TNF-α, the immune system was capable of developing Th1 
response afterwards sufficient enough to resolve the infection (Elizondo et al., 2011).  
6 Conclusion
First studies of leishmaniasis attributed enhanced susceptibility to incorrect decision of the 
immune system of the host to drive Th2 response aimed to extracellular pathogens which was evoked 
by phagocytosis induced by parasites. Many of the experiments of gene targeted mutations analysed in 
this thesis led to worsened outcomes or even succumbing to the disease in comparison with WT due to 
reduced levels of IFN-γ and/or IL-12 or on the contrary because of an overproduction of Th2 
cytokines especially IL-4, IL-5, IL-13 and IL-10. Thus, Th1/Th2 polarization is crucial in the response 
to L. major indeed. But it is demonstrated here that there are other processes independent on Th 
signalling which contribute to manifestations of leishmaniasis. For example it is a defect of chloride 
channels of phagocytes leading to an increase of phalysosomal pH in STAT1 deficient mice (Späth et 
al., 2009), an overproduction of IL-1 in mice knocked out in its receptor antagonist (Voronov et al., 
2010) or a presence of STAT4 independent signalling (Stamm et al., 1999). These mechanisms are yet 
not all involved. For instance a work of Kinjyo et al. showed a significant role of SOCS3 whose 
deficiency resulted in differentiation of T lymphocytes into TGF-β producing Th3 cells that supress 
both Th1 and Th2 cell activity (Kinjyo et al., 2006). Next, enhanced sensitivity when Il6 gene was 
knocked out was a cause of intensified proliferation of IL-10 secreting Treg cells rather than Th2 cells 
even though Th2 response was in fact evoked (Wu et al., 2009). In addition the research of Satoskar et 
al. demonstrated an important function of IL-6 inhibiting MIF whose absence did not have any impact 
on neither Th1 nor Th2 cytokines but still displayed enhanced susceptibility most likely as a 
consequence of macrophages dysfunction caused by association of IL-6 and SOCS3 (Satoskar et al., 
2001). It is also necessary not to forget cell receptors such as ITGAM through which the parasites can 
enter cells easily and apoptosis signalling genes as their deficiency induces impaired NO production 
and hence the elimination of parasites as well.
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The reality is therefore more complicated than it was supposed initially. The response of the host 
to L. major is a complex network of molecules whose misbalance or single absence may lead to a 
chain of irreversible reactions causing a successful dissemination of parasites. Knock-outs enhancing 
both the susceptibility and resistance help us to learn about sophisticated strategies of Leishmania
parasites as well as genes involved in response to this parasite. As the course of leishmaniasis is 
directed by a greater number of genes which may be often revealed by QTL mapping, there are many 
new studies coming out annually that investigate the effects of the candidate genes by their targeted 
mutations or other methods too. Only this year, analysis by Masoud Akbari et al. of Irf4 deficiency or 
by Sachiko Sato et al. explaining the interaction of galectin-3 and surface molecules of Leishmania
parasites which is also mentioned in this thesis has been published. Resulting from a cooperation of 
methods of forward and reverse genetics these works can hence be efficiently applied for gene therapy 
or design of new vaccines to fight not only with Leishmania parasites but also other intracellular 
pathogens and can help us to understand the metabolic pathways and gene expression of their 
intermediates in response to L. major in our immune system.
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8 Attachments
Table 1: An overview of performed gene targeted mutations in order of their position on chromosomes with description of mouse and parasites strains and with the outcome 
of the disease compared to the WT mice
Targeted gene, position Mouse strain Parasite Outcome in comparison with WT unless otherwise stated References
Stat4
Chr. 1, 26,67 cM, 52,008 Mb






promastigotes inoculated in the hind 
footpad 
Similar IL-4, IL-12, IgG1 and IgE as WT
 IFN-γ, IgG2a
Possible Stat4 independent  IL-12 signalling pathway but not 
sufficient enough to develop Th1 response
Progressive non-healing lesions that contained significantly 
higher numbers of parasites
Extensive subcutaneous tissue destruction
(Stamm, et al., 1999)
Stat1
Chr. 1, 26, 81 cM, 52,119 Mb
Signal transducer and activator of 
transcription 1
129/Sv
L. major strain LV39 clone V (Rho/SU/59/P)
10
6 
promastigotes inoculated  into the 
footpad
 phago-lysosomal pH
Defect in Cl channels
Progressive non-healing lesions
(Späth, et al., 2009)
C57BL/6
L. major, LV 39
2 × 106 promastigotes into the footpad
 IL-10, levels of IL-4, TGF-β not altered
 IFN-γ, IL-12, NO
Possible IFN-γ independent Stat1 pathway
Progressive non-healing lesions
Extensive subcutaneous tissue destruction
(Rosas, et al., 2003)
Il1rn 






metacyclic promastigotes inoculated 
intradermally in ear skin of mice (Katz-Neu)
IL-6, a IL-17, DCs, neutrophils
Normal IL-4, IL-10
 IFN-γ, IL-12 
Progressive non-healing lesions
58-fold higher (to WT) parasite number in lesions 8 wk post 
infection and also increased parasite number in spleens
(Kautz-Neu, et al., 2011)
BALB/c
L. major (MHOM/IL/80/Friedlin)
107 promastigotes inoculated  
subcutaneously at the base of the tail 
(Voronov)
 IL-4, IL-10, IL-6, a IL-17, DCs, neutrophils
 IFN-γ, IL-12 
Development of nodules
Extensive subcutaneous tissue destruction
Significant increase in parasite load in both liver and spleen
(Voronov, et al., 2010)
31
Notch1, Notch2 
Chr. 2 (N1), 18,91 cM, 26,457 Mb
Chr. 3 (N2), 42,24 cM, 98,013 Mb
C57BL/6 
Cre-LoxP system used
L. major LV39 (MRHO/Sv/59/P strain) 




Possible direct effect on IL-4 promoter
Progressive non-healing lesions
Parasite dissemination to the lymph nodes and spleen 
(Auderset, et al., 2012)
Ras, Hras, Nras isoforms
Chr. 3 (Nras), 45,25 cM, 103,058 Mb
Chr. 7 (Hras), 86,48 cM, 141,189 Mb
Harvey rat sarcoma virus oncogene, 
Neuroblastoma ras oncogene
KO mice backcrossed to 
C57BL/6 background for 
≥ 6 generations
L. major clone V1
300 metacyclic promastigotes inoculated into 
the ear intradermaly
Impaired induction of TF T-bet   IFN-γ
Normal IL-4, later increased levels
IgG1 (specific for Th2) detected
Failure to develop Th1 response
Progressive non-healing lesions
Increased parasite number in the site of infection and lymph 
nodes 12 wk post infection
(Iborra, et al., 2011)
Nfkb
Chr. 3, 62,82 cM, 135,584 Mb
Nuclear factor of kappa light 
polypeptide gene enhancer in B cells
C57BL/6 × 129 
background backcrossed 
to C57BL/6 ≥ 8 
generations
L. major (MHOM/IL/80/Friedlin)
5 × 106 promastigotes inoculated in the hind 
left footpad
IFN-gamma
Without an effect on Th polarization
Defect in CD4+ T cells differentiation
Large progressive non-healing lesions
Extensive subcutaneous tissue destruction
Number of parasites in lesions was not significantly greater 
possible ability to control parasite replication to some extent
(Artis, et al., 2003)
Il6
Chr. 5, 15,70 cM, 30, 010 Mb
Interleukin-6
C57BL/6
L. major clone VI, L. major/CpG
(MHOM/IL/80/Friedlin)
1 x 104 promastigotes inoculated 
intradermally in the ear
 IL-10, Treg cells (in both Lm and Lm/CpG infected mice) 
 IFN-γ, IL-12 (Lm/CpG)
 CD4+ T cells, IL-12, IFN-γ (Lm)
Progressive non-healing lesions and tissue necrosis
Elevated parasite numbers in lesions
(Wu, et al., 2009)
Il27ra  (WSX-1) 
Chr. 8, 40,26cM, 84,030 Mb
Class I cytokine receptor
129/J × C57BL/6 
backcrossed to C57BL/6
for ≥ 9 generations 
L. major (MHOM/SU/73-5-ASKH)
5 x 106 promastigotes inoculated 
subcutaneously n the right hind footpad
  IL-4, IL-13, IgG1, IgE
↓ IFN-γ, but later no impairment in its production 
Normal IgG2a
Progressive non-healing lesions
Increased footpad swelling and severe ulceration
(Yoshida, et al., 2001)
Ccr2
Chr. 9, 75,05 cM, 124,101 Mb
C-C chemokine receptor 
KO mice backcrossed to 
C57BL/6J background for 
≥10 generations
(or C57BL/6 × 129 
similar results)
L. major clone VI (MHOM/IL/80/Friedlin)
2 × 106 or 1 × 107 promastigotes inoculated 
intradermaly into both ears 
 IL-12, CCL-19, MHC II
Failure to develop Th1 response
Impaired recruitment of DCs
(Jimenez, et al., 2010)
32
Tlr9
Chr. 9, 57,49 cM, 106,222 Mb 
Toll-like receptor-9 
KO mice backcrossed to 
C57BL/6 for ≥ 10 
generations
L. major LV39
3 ×106 promastigotes inoculated in the 
footpad
 IFN-gamma, IL-12
Inhibition of Th1 response
Reduced maturation of DCs
Large non-healing lesions present even 7 wk post infection
Higher number of parasites in lesions and lymph nodes 4 wk 
post infection
(Fakher, et al., 2009)
Myd88 
Chr. 9, 71,33 cM, 119,335 Mb 
Myeloid differentiation primary 
response gene 88
KO mice backcrossed to 
C57BL/6 for 8 
generations
L. major (MHOM/IR/–/173 strain)
5 × 106 promastigotes inoculated 





Lesion size similar to observed in BALB/c
(Muraille, et al., 2003)
Mif 








No impairment in IFN-g, IL-4, IL-10, IL-12, TGF-β 
production - no significant impact on Th polarization
Macrophage dysfunction
Large progressive lesions development
Greater parasite burdens (in footpad ≥ 100-fold)
(Satoskar, et al., 2001)
Ifng
Chr. 10, 66,75 cM, 118,441 Mb
Interferon-gamma
KO mice backcrossed to 
C57BL/6 for 7 
generations
L. major (strainWHOM/IR)
106 promastigotes inoculated in the hind 
footpads)
CD4+ T cells develop typical Th2 response
  IL-4, IL-5, and IL-13, IgG1, IgE
 IgG2a and IgG3
Large lesions development, severe footpad swelling
Deaths from 5 to 7 wk post infection occurred
Hypertrophy of lymph nodes and spleen
Radically increased number of parasites in footpads
(Wang, et al., 1994)
Socs 3
Chr. 11, 82,96 cM, 117,966 Mb
Suppressor of cytokine signalling 3
129 × C57BL/6 
Cre-LoxP system
L. major (MHOM/SU/73-5-ASKH)
107 promastigotes inoculated subcutaneously 
in the right footpad 
 TGF-b1, IL-10, Th3 cells 
 IL-12 (inhibition of Th1 differentiation)
Footpad swelling similar to WT
Higher parasite number in lesions remaining 6 wk post 
infection
(Kinjyo, et al., 2006)
Lgals3
Chr. 14, 24,60 cM, 47,367 Mb
Lectin, galactose binding, soluble 3
KO mice backcrossed to 
BALB/c for nine 
generations
L. major LV 39
1 ×107 promastigotes were inoculated into 
the one hind footpad
 IL-10, TGF-β, Notch1, Hes-1 (Notch target gene), Treg 
cells
Increased footpad swelling from 5th wk post infection and 
number of parasites in lesions from 2nd wk post infection
(Fermino, et al., 2013)
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Mapk8 (Jnk1)
Chr. 14, 20,22 cM, 33,377 Mb
J-N (Janus)-terminal kinase 
129 × C57BL/6
L. major WR309
2 × 106 promastigotes inoculated in to the 
right hind footpad
 IL-5, IL-13, Th2 dependent IgG1
Normal NO and IL-12 production
Ability to develop Th1 but simultaneous generation of Th2 
response
Pattern of lesion formation almost identical to the one 
observed in BALB/c
(Constant, et al., 2000)
Socs1
Chr. 16, 5, 81 cM, 10,783 Mb
Suppressor of cytokine signaling-1
C57BL/6 × 129/Sv
backcrossed to C57BL/6 
mice for ≥10 generations
L. major LRC-L137 
(MHOM/IL/67/Jericho II)
1 × 104 V121 promastigotes inoculated 
intradermally  into the pinna of the ear
SOCS1+/- led to normal Th1 response ( IFNγ,  IL-4, IL-10) 
but developed significantly large progressive lesions
Similar parasite burden to one observed in WT
SOCS1-/- (IFNγ-/-)  fatal inflammatory liver disease an overall
inability to resolve the disease
(Bullen, et al., 2003)
Bcl6
Chr. 16, 15,26 cM, 23,965 Mb
B-cell lymphoma 6
129 × C57BL/6
L. major strain V1 
(MHOM/IL/ 80/Friedlin)
106 promastigotes innoculated  
subcutaneously in the right hind footpad
 IL-4, IL-5, IL-13 
 IFN-γ
Early deaths (5 wk post infection) occurred
Severe footpad swelling, skin ulcers and tissue 
necrosis(similar to BALB/c)
Number of parasites in lymph nodes comparable to BALB/c
BCL6-/- IL4-/- mice susceptible
BCL6-/-  STAT6-/- mice resistant
(Dent, et al., 1999)
H-2b (MHC II)
Chr. 17, cytoband B-C
Major histoncompatibility complex 
class II
KO mice backcrossed to 
C57BL/6 for 5 
generations
L. major LV 39 
105 promastigotes inoculated in the hind 
footpad
 activity of CD8 T cells 
 CD4 T cells, IFN-γ 
Large lesion development in comparison with WT
High number of parasites in lesions remains 65 days post 
infection while in WT no parasites detected at this time
Early infection controlled but later exacerbated
(Chakkalath, et al., 
1995)
Ier3 (IEX-1)
Chr. 17, 18.70 cM, 35, 821 Mb
Immediate early response 3 
129Sv × C57BL/6 
L. major Friedlin V1 (MHOM/IL/80/FN)
1 × 106 metacyclic promastigotes inoculated 
intradermally into the ear
 IL-17, IL-10
Treg cells, TNF-α, NO
No effect on Th polarization 
Progressive lesion development and delayed healing 
phenotype
Tissue damage began 4 wk post infection (100-fold increase 
in the parasite load in the infected ears)
(Akilov, et al., 2009)
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Tnf
Chr. 17, 18, 59 cM, 35,199 Mb
Tumour necrosis factor
C57BL/6
L. major promastigotes 
(MHOM/IL/81/FEBNI)
3× 106 promastigotes inoculated 
subcutaneously into footpad 
Delay of the induction of Th1 cells
Accumulation of infected cells in their lesions
 NO
Moderate increase in lesion size, no ulceration observed
Parasite burden comparable to WT but 6 wk post infection 
significant increase detected
Deaths from 6 to 9 wk post infection occurred
(Wilhelm, et al., 2001)
Fas/FasL 
Chr. 19 (Fas), 29,48 cM, 34,290 Mb
Chr. 1 (Fasl), 69,95 cM, 161,780 Mb
(APO1) Apoptosis antigen 1
C57BL/6 and C3H/HeN 
(Fas-deficient mice on a 
C57BL/6 background 
only)
L. major LV 39 (MRHO/SU/59/P-strain)
2 × 106 promastigotes inoculated 
subcutaneously in one hind footpad
No impairment in IFN-γ and IL-4 production
 NO
Ability to develop Th1 response
Progressive lesion development
Higher parasite numbers in lesions (reaching values 100-fold 
higher to WT 3 months post infection)
Phenotype was not as severe as in BALB/c mice
(Conceicao-Silva, et al., 
1998)
Cd40lg
Chr. X, 31,21 cM, 57,212 Mb
CD40 ligand
C57BL/6 × 129/ J
L. major (MHOM/IL/80/Friedlin strain)
2 - 5 × 105 promastigotes inoculated in the 
hind footpad
 IL-4, IL-10
 IFN-γ, IL-2, IL-12
Failure to develop Th1 response
Progressive ulcerating lesions development
Increased footpad swelling
(Campbell, et al., 1996)
Gene KO enhancing the resistance Mouse strain Parasites Outcome in comparison to WT unless otherwise stated References
Il17 (Ctla-8)
Chr. 1, 6,45 cM, 20,730 Mb 
Cytotoxic T lymphocyte associated 
antigen 8
KO mice backcrossed to 
BALB/c for ≥ 10 
generations
L. major  V1(MHOM/IL/80/Friedlin)
1 × 103 or 2 x 105 promastigotes inoculated 
intradermally in the ear
Th2 development
 CXCL2, neutrophils in site of infection
Similar IFN-γ, IL-4, IL-10 as in BALB/c
Similar DC recruitment as in resistant mice
Possible role in neutrophil recruitment
Significantly smaller lesions and lower parasite burdens
Inability to resolve the lesions contrary to C57BL/6 mice
(Kostka, et al., 2009)
Il1a




107 promastigotes inoculated  
subcutaneously at the base of the tail
 IL-12, IL-18, IFN-γ 
 IL-4, IL-6 IL-10, IL-17
Less or no parasites detected in both liver and spleen
Only late, moderate splenomegaly and mild signs of hepatitis
Minimum nodules development
No significant change in number of T cells and macrophages
(Voronov, et al., 2010)
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Itgam (CR3), CD11b chain
Chr. 7, 69.93 cM, 128,062 Mb 
Complement Receptor 3
Integrin alpha M
129/J × C57BL/6 
backcrossed to both 
BALB/c and C57BL/6 for 
8 times
L. major (MHOM/IL/80/Friedlin)
1 × 103 or 105 promastigotes inoculated 
intradermally in the ear
Similar profiles of Th1 and Th2 cytokine production as well 
as parasite burdens in BALB/c WT and KO mice
From week 8 lesions began to decrease in size
Reduced tissue damage and delayed necrosis
Infection is less severe in CD11b-deficient mice than in 
BALB/c WT animals but parasites are probably able utilize 
other receptors as mechanisms of entry
(Carter, et al., 2009)
Il13
Chr. 11, 31,98 cM, 53,631 Mb
Interleukin-13
KO mice backcrossed to 




2 × 106 promastigotes inoculated in the hind 
footpad 
  IL-5 and  IFN-γ (when overexpressed in resistant mice)
Overexpression of IL-13 led to inability to resolve the
infection independently on IL-4
IL-13-/- and IL-13-/-IL-4-/- mice were able to control the 
infection and by day 56 had normal footpads
Additive effect of deleting both IL-4 and IL-13 on resistance
(Matthews, et al., 2000)
Ccl2 (MCP-1)
Chr. 11, 49,82 cM, 82,035 Mb 
Monocyte chemoattractant protein-1 
BALB/c
L. major
2 × 106 promastigotes innoculated  
subcutaneously in the hind footpad
 IL-4, IL-5, IL-10
No impairment of IFN-γ, IL-2, IL-12 production
KO mice are nearly Th2 deficient
Significantly less footpad swelling than BALB/c
Delayed healing phenotype in comparison with C57BL/6
Phenotype between completely susceptible and completely 
resistant strains
(Gu, et al., 2000)
Ahr




3 × 106 promastigotes inoculated in the hind 
footpad 
Firstly ↓IL-12 and ↑ IL-10 later typical Th1 response
 IFN-γ, IL-12, TNF-α
 IL-4, IL-10
Decrease in number of parasites in footpads
Decrease in lesion size 4 wk post infection
(Elizondo, et al., 2011)
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Figure 5: An overview of products of knocked out genes and the pathways in which they are involved. The map was created based on 
the information took from the articles of particular KO and from Pathwaymaps of Thomson Reuters
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Abbreviations used in Figure 5
Ahr Aryl hydrocarbon receptor
Akt Thymoma viral proto-oncogene
AP1 Activator protein 1
Arp Arp lymphoid/erythroid hyperplasia
ATF2 Activating transcription factor 2
Bcl2, 6 B cell leukemia/lymphoma 2, 6
CCL2 Chemokine (C-C motif) ligand 2
CCR2 Chemokine (C-C motif) receptor 2
CD40, 74 Cluster of differentiation 40, 74 antigen
CD40L Cluster of differentiation 40 ligand
cfos FBJ osteosarcoma oncogene
c-Jun Jun proto-oncogene
c-Myc Myelocytomatosis oncogene
CR3 (Itgam) Integrin alpha M
Erk Extracellular signal-regulated kinase
FADD Fas-associated via death domain
FASL Fas ligand
FASR Fas receptor
GATA3 GATA binding protein 3
Icam1 Intercellular adhesion molecule 1




IL-xR Interleukin receptor x
Irf Interferon regulatory factor 1
Jak1, 2 Janus kinase 1, 2
Jnk1 (Mapk8) Mitogen-activated protein kinase 8
Lck Lymphocyte protein tyrosine kinase
Lgals3 Lectin, galactose binding, soluble 3
Mapk Mitogen-activated protein kinase
MHC II Major histoncompatibility complex class II
Mif Macrophage migration inhibitory factor
MyD88 Myeloid differentiation primary response gene 88
NF-kB Nuclear factor of kappa light polypeptide gene enhancer in B cells
p38 p38 mitogen-activated protein kinase
PI3K Phosphoinositide 3-kinase
Raidd (Cradd) CASP2 and RIPK1 domain containing adaptor with death domain
Ras Rat sarcoma virus oncogene
RBP-Jk Recombination signal binding protein for immunoglobulin kappa J 
region
Rip Regulation of phenobarbitol-inducible P450
Socs Suppressor of cytokine signaling
Stat Signal transducer and activator of transcription
T-bet (Tbx21) T-box 21
TCR T-cell receptor
TLR Toll-like receptor
Tnf Tumor necrosis factor
TnfR Tumor necrosis factor receptor
Tradd TNFR-associated via death domain
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